(Q89707188)

English

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

scientific article published on 13 February 2020

Statements

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit